Article

Bladder Cancer Matters Podcast Part 2: Why Bladder Cancer Patients May Need an Oncology Social Worker with Dr. Heather Goltz

In Episode 2 of the “Bladder Cancer Matters” podcast, host Rick Bangs interviews Dr. Heather Honoré Goltz in Part 2 of a two-part episode.

In Episode 2 of the “Bladder Cancer Matters” podcast, host Rick Bangs interviews Dr. Heather Honoré Goltz in Part 2 of a two-part episode. Rick and Dr. Goltz discuss what oncology social work is and how it might be helpful to bladder cancer patients. Topics covered in the podcast include:

  • How to find an oncology social worker to work with;
  • Benefits for bladder cancer patients of working with an oncology social worker;
  • When in your cancer journey it’s best to start working with someone; and more.

This episode is sponsored by FerGene, a new gene therapy company dedicated to creating and delivering innovative solutions for bladder cancer.

Related Videos
Image of a man with rectangular glasses and a goatee.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Dr. Psutka in an interview with CURE
Dr. Sarah Psutka in an interview with CURE at the ASCO Annual Meeting
Kristie L. Kahl and Dr. Tracy L. Rose
Dr. Tracy Rose
Dr. Tracy L. Rose
Kristie L. Kahl and Tracy L. Rose
Related Content
Illustration of bladder.
December 19th 2024

UGN-102 May Improve Quality of Life Versus Surgery in Bladder Cancer

Ashley Chan
Treatment with UGN-102 has shown promise as a non-surgical alternative when compared with a surgical approach for certain patients with bladder cancer.
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
January 30th 2024

Highlights from the Gastrointestinal and Genitourinary Cancer Conferences

Alex Biese Brielle Benyon
Here are some of the top stories from the recent Gastrointestinal Cancers Symposium as well as the Genitourinary Cancers Symposium.
Illustration of bladder.
November 25th 2024

Opdivo May Improve Outcomes in High-Risk Muscle-Invasive Bladder Cancer

Spencer Feldman
Adjuvant Opdivo showed a significant improvement in overall survival and disease-free survival for patients with high-risk muscle-invasive urothelial cancer after radical resection.
cancer horizons podcast logo
December 20th 2023

FDA Approves 3 Treatments, Cancer Vaccine Shows Promise

Alex Biese Brielle Benyon
The Food and Drug Administration recently approved treatment for some patients with neuroblastoma, kidney cancer and bladder cancer. Elsewhere, a cancer vaccine made headlines for the treatment of patients with melanoma.
Illustration of bladder.
November 21st 2024

UGN-102 Shows Promising Treatment Responses in Recurrent Bladder Cancer

Ashley Chan
Treatment with UGN-102 in patients with recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer demonstrated beneficial responses.
FDA Approval Withdrawal of Trodelvy Leaves Fewer Bladder Cancer Options
November 6th 2024

FDA Approval Withdrawal of Trodelvy Leaves Fewer Bladder Cancer Options

Alex Biese
The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.